home-page-logo

From Concept to Clinic
to the Commercial Market.

YOUR RADIOPHARMACEUTICAL DEVELOPMENT PARTNER.

At CPDC we are working with our partners to discover, develop and distribute the next generation of imaging agents and targeted radiotherapeutics for the detection and treatment of human diseases.

What Are Radiopharmaceuticals?

Radiopharmaceuticals are a special class of drugs. They’re sometimes called molecular imaging probes, contrast agents, tracers or radiotherapeutics.

Radiopharmaceuticals contain a radioactive isotope and they are used to both diagnose and treat disease.  Millions of patients receive radiopharmaceuticals annually for a wide variety of medical procedures ranging from the assessment of cardiac function to staging and treatment of cancer.

CPDC In-Licenses Enabling Technology to Advance Effectiveness of Immunotherapy

The Centre for Probe Development and Commercialization (CPDC) at McMaster University in Hamilton, Ontario, announces that it has licensed the Centyrin® platform from Janssen Biotech, Inc. for exclusive use in combination with its radiopharmaceutical expertise to create novel nuclear imaging probes against immunotherapy drug targets. Immunotherapy has become one of the most active areas in

Do you love radiopharmaceuticals as much as we do?

CPDC is always looking for exceptional people to strengthen our team.

Join Our Team

For more information contact us at: